Search

everythinglearnresearchcommunity

for

Search:↓

CircAGK affects cell death in hair cells by controlling the miR-3180-5p/BAX pathway, which can lead to hair loss.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Clascoterone may be a promising treatment for hair loss.

More research is needed on CCCA in children, especially Black and Asian adolescents.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Type XVII collagen helps control skin cell growth and could be a target for anti-aging treatments.

The Hedgehog signaling pathway is important for skin and hair growth and can lead to cancer if it doesn't work right.

Retinoic acid can either maintain stem cells or make them specialize, depending on the cell type.

Basal cell carcinomas need extra mutations to grow from small to large tumors.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

Hair loss is caused by the breakdown of a protein called COL17A1 in hair follicle stem cells.

Understanding skin stem cells and their regulation is key to improving skin healing and treating disorders.

Special gels help heal diabetic foot sores and reduce the risk of amputation or death.

WWOX deficiency in mice causes skin and fat tissue problems due to disrupted cell survival signals.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Disrupted stem cell signals in hairpoor mice cause hair loss.

Wnt signaling is crucial for skin, hair, and nail health and regeneration.

Epigenetic changes in skin cells contribute to aging, but targeting these changes may offer new antiaging treatments.

Type XVII collagen helps control skin cell growth and may have anti-aging effects.

Type XVII collagen may help prevent skin aging.

The dog's health improved after treatment with antibiotics and other medications.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Keratin-associated proteins are part of the developing hair fiber cuticle.

Clitocybin A can promote hair growth by increasing cell proliferation.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.